Let's E.A.T.! (Eating With Assistive Technology): An Intervention to Support Children With Feeding Tubes and Tracheostomies
Launched by UNIVERSITY OF CHICAGO · Jul 25, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The "Let's E.A.T.!" clinical trial is designed to help young children who rely on feeding tubes and have tracheostomies (a tube in their neck to help them breathe) to transition to eating by mouth. The study will provide a special program that combines in-home visits and virtual sessions led by a team of experts, including occupational therapists, speech therapists, and dietitians. The goal is to improve the children's ability to eat orally and help their families feel more confident and less worried about feeding.
To be eligible for this study, children must be under 3 years old, live at home, have a feeding tube and a tracheostomy, and be located within an hour's drive from the University of Chicago. Participants will take part in weekly sessions, both in person and online, where they will receive support and guidance from the care team. This trial is important because it aims to find effective ways to meet the feeding needs of children with complex medical issues, making it easier for families to access specialized care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Under 3 years of age
- • Reside at a family home
- • Have a gastrostomy feeding tube
- • Have a tracheostomy
- • Live within a 1-hour radius of the University of Chicago
- Exclusion Criteria:
- • • Wards of the state
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Sarah Sobotka, MD, MSCP
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported